(Q37829629)

24 August 2017

1 reference

title

Simian immunodeficiency virus macaque models of HIV latency (English)

1 reference

Simian immunodeficiency virus

24 August 2017

0 references

0 references

0 references

2

Raymond F Schinazi

1 reference

24 August 2017

Jesse D Deere

1

1 reference

PubMed ID

21242894

24 August 2017

Thomas W North

series ordinal

3

1 reference

24 August 2017

1 January 2011

1 reference

Current Opinion in HIV and AIDS

24 August 2017

1 reference

24 August 2017

6

1 reference

24 August 2017

1

1 reference

24 August 2017

57-61

1 reference

Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenine

24 August 2017

1 reference

12 December 2020

Sensitivity/resistance profile of a simian immunodeficiency virus containing the reverse transcriptase gene of human immunodeficiency virus type 1 (HIV-1) toward the HIV-1-specific non-nucleoside reverse transcriptase inhibitors

1 reference

12 December 2020

Animal model for the therapy of acquired immunodeficiency syndrome with reverse transcriptase inhibitors

1 reference

12 December 2020

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

1 reference

12 December 2020

Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

1 reference

12 December 2020

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

1 reference

12 December 2020

Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

1 reference

12 December 2020

Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection

1 reference

12 December 2020

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

1 reference

12 December 2020

Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy.

1 reference

12 December 2020

Genetic characterization of rebounding HIV-1 after cessation of highly active antiretroviral therapy

1 reference

12 December 2020

Real-time TaqMan PCR as a specific and more sensitive alternative to the branched-chain DNA assay for quantitation of simian immunodeficiency virus RNA.

1 reference

12 December 2020

A nucleotide substitution in the tRNA(Lys) primer binding site dramatically increases replication of recombinant simian immunodeficiency virus containing a human immunodeficiency virus type 1 reverse transcriptase

1 reference

12 December 2020

Virulence and reduced fitness of simian immunodeficiency virus with the M184V mutation in reverse transcriptase

1 reference

12 December 2020

Resting CD4+ T lymphocytes but not thymocytes provide a latent viral reservoir in a simian immunodeficiency virus-Macaca nemestrina model of human immunodeficiency virus type 1-infected patients on highly active antiretroviral therapy

1 reference

12 December 2020

Susceptibilities of Simian Immunodeficiency Virus to Protease Inhibitors

1 reference

12 December 2020

Productive infection maintains a dynamic steady state of residual viremia in human immunodeficiency virus type 1-infected persons treated with suppressive antiretroviral therapy for five years

1 reference

12 December 2020

New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma

1 reference

12 December 2020

Efavirenz therapy in rhesus macaques infected with a chimera of simian immunodeficiency virus containing reverse transcriptase from human immunodeficiency virus type 1.

1 reference

12 December 2020

In vitro characterization of a simian immunodeficiency virus-human immunodeficiency virus (HIV) chimera expressing HIV type 1 reverse transcriptase to study antiviral resistance in pigtail macaques

1 reference

12 December 2020

Suppression of virus load by highly active antiretroviral therapy in rhesus macaques infected with a recombinant simian immunodeficiency virus containing reverse transcriptase from human immunodeficiency virus type 1.

1 reference

12 December 2020

Evidence that low-level viremias during effective highly active antiretroviral therapy result from two processes: expression of archival virus and replication of virus

1 reference

12 December 2020

Suppression of viremia and evolution of human immunodeficiency virus type 1 drug resistance in a macaque model for antiretroviral therapy

1 reference

12 December 2020

Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy

1 reference

12 December 2020

Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel

1 reference

12 December 2020

A macaque model of HIV-1 infection

1 reference

12 December 2020

Early antiretroviral treatment prevents the development of central nervous system abnormalities in simian immunodeficiency virus-infected rhesus monkeys

1 reference

12 December 2020

A simian immunodeficiency virus-infected macaque model to study viral reservoirs that persist during highly active antiretroviral therapy

1 reference

12 December 2020

Evaluation of antiretrovirals in animal models of HIV infection.

1 reference

12 December 2020

Antiretroviral therapy in macrophages: implication for HIV eradication

1 reference

12 December 2020

RT-SHIV subpopulation dynamics in infected macaques during anti-HIV therapy

1 reference

12 December 2020

RT-SHIV, an infectious CCR5-tropic chimeric virus suitable for evaluating HIV reverse transcriptase inhibitors in macaque models

1 reference

12 December 2020

Viral sanctuaries during highly active antiretroviral therapy in a nonhuman primate model for AIDS

1 reference

12 December 2020

CD8+ lymphocytes control viral replication in SIVmac239-infected rhesus macaques without decreasing the lifespan of productively infected cells

1 reference

12 December 2020

In vivo CD8+ T-cell suppression of siv viremia is not mediated by CTL clearance of productively infected cells

1 reference

12 December 2020

Response of a simian immunodeficiency virus (SIVmac251) to raltegravir: a basis for a new treatment for simian AIDS and an animal model for studying lentiviral persistence during antiretroviral therapy

1 reference

12 December 2020

Proton magnetic resonance spectroscopy reveals neuroprotection by oral minocycline in a nonhuman primate model of accelerated NeuroAIDS

1 reference

12 December 2020

Simian immunodeficiency virus-infected macaques treated with highly active antiretroviral therapy have reduced central nervous system viral replication and inflammation but persistence of viral DNA

1 reference

12 December 2020

Impact of short-term combined antiretroviral therapy on brain virus burden in simian immunodeficiency virus-infected and CD8+ lymphocyte-depleted rhesus macaques

1 reference

12 December 2020

Viral decay kinetics in the highly active antiretroviral therapy-treated rhesus macaque model of AIDS.

1 reference

12 December 2020

10.1097/COH.0B013E32834086CE

Identifiers

DOI

1 reference

24 August 2017

0 references

1 reference

PubMed ID

21242894